BeStock  
Stocks › Biotechnology › BCAX

Bicara Therapeutics BCAX

US equityMarket cap rank #3186Biotechnology
$16.42 −$0.14 (-0.85%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $16.42 0.00%
Open$16.44
Prev close$16.56
Day range$16.25 – $17.11
Volume915.6K
Market cap$1.09B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$36.67+123.3% vs. price
  • Buy 100%
Low $30.00Now $16.42Avg $36.67High $45.00

Recent rating changes

The last 20 actions on file set price targets from $28.00 to $46.00, averaging $35.47.

DateFirmRatingTarget
7 Oct 2026 BMO Capital BUY $35.00
8 Sep 2026 JonesTrading BUY $30.00
18 Aug 2026 BMO Capital BUY $35.00
13 Aug 2026 Stifel BUY $45.00
12 Aug 2026 BTIG BUY $39.00
12 Aug 2026 Morgan Stanley BUY $37.00
11 Aug 2026 JonesTrading BUY $30.00
11 Aug 2026 BofA Securities BUY $34.00
27 Jul 2026 BTIG BUY $28.00
2 Jun 2026 BofA Securities BUY –
1 Jun 2026 H.C. Wainwright BUY $42.00
26 May 2026 Guggenheim BUY $42.00
22 May 2026 JonesTrading BUY $30.00
22 May 2026 BofA Securities BUY –
12 May 2026 Morgan Stanley BUY $37.00
12 May 2026 Stifel BUY $46.00
11 May 2026 TD Cowen BUY –
11 May 2026 JonesTrading BUY $30.00
11 May 2026 BTIG BUY $28.00
11 May 2026 BofA Securities BUY $35.00

Discussion

No comments yet — be the first to weigh in on BCAX.

Leave a comment

Scroll to Top